Cytomegalovirus (CMV) Infection in Amniotic Fluid
Completed
Conditions studied: Pregnancy Complications, Cytomegalovirus Infections
In brief
The purpose of this study is to determine if detection of cytomegalovirus (CMV) in amniotic fluid collected in the second trimester of pregnancy is associated with pregnancy complications such as preterm delivery or severe preeclampsia.
Key facts
- Study ID
- NCT00194142
- Run by
- University of Pennsylvania
- People needed
- 37
- Starts
- 2007-07-01
- Expected to finish
- 2008-05-01
- Last updated by the study team
- 2016-08-17
Who can join
Age: 15 and older, up to 45. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Women who deliver at term without pregnancy complications
- Women who deliver (preterm, less than 37 weeks of gestation) as a result of spontaneous preterm labor
- Women whose pregnancies are complicated by severe preeclampsia
You may not qualify if…
- Women with multi-gestational pregnancies, or whose pregnancies are complicated by a congenital malformation or chromosomal abnormality
- Women who have a medical history of hypertension (high blood pressure), diabetes, or severe renal (kidney) disease
Where it is running
- Hospital of the University of Pennsylvania — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.